Piramal Enterprises has received approval from Board of Directors to raise up to Rs 100 crore along with an option to retain over subscription of up to Rs 100 crore, aggregating up to Rs 200 crore through Secured, Rated, Listed, Redeemable, Principal Protected, Market Linked Non-Convertible Debentures (NCDs) on private placement basis. The Board of Directors at its meeting held on July 12, 2021 has approved the same.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
